等待開盤 03-26 09:30:00 美东时间
0.000
0.00%
DraftKings (DKNG) stock drops as prediction market competition from Kalshi and Polymarket intensifies. Read why analysts are cutting estimates and how regulatory heat from AOC and Martin Shkreli is impacting the sports betting sector.
今天 03:00
Costco Wholesale (COST) has quietly launched a new Kirkland energy drink at some stores. While the company has not issued a formal announcement with details about the launch, social media accounts hav...
今天 01:39
Alteogen on Wednesday announced an exclusive license agreement with Biogen (BIIB) to develop subcutaneously delivered biologics leveraging the South Korean pharma's Hybrozyme platform technology. At t...
今天 00:20
Takeda (TAK) announced plans to generate more than ¥200B ($1.3B) in annualized gross savings by fiscal 2028 on Wednesday, citing a business transformation exercise and a recently undertaken restructur...
03-25 22:27
BUZZ-Apogee Therapeutics resumes climb after $350 mln share sale ** Apogee Therapeutics APGE.O shares up 13.3% at $82.68 early Weds after $350 mln follow-on offering priced ** Waltham, Massachusetts-based firm late Tues announced 5 mln shares at $70, a 4.1% discount to last sale ** On Tues, APGE sha
03-25 22:14
Sarepta Therapeutics (SRPT) added ~25% in the morning hours on Wednesday after the company posted initial data from Phase 1/2 trials for its experimental drugs targeted at two rare forms of muscular d...
03-25 21:49
Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in...
03-25 20:44
SSR Mining (SSRM) up 5.3% pre-market Wednesday after confirming an agreement to sell its 80% ownership stake in the Çöpler mine and related properties in Turkey to Cengiz Holding, one of the country's...
03-25 19:47
Nanobiotix (NBTX) shares rose ~7% in Paris on Wednesday after the French publication La Lettre reported that U.S. pharma giant Johnson & Johnson (JNJ) is eyeing a buyout deal to acquire the cancer dru...
03-25 19:03
Apogee Therapeutics prices USD 350 million follow-on offering at USD 70 per share Apogee priced an underwritten public offering of 5,000,000 common shares at USD 70 per share. Gross proceeds are expected to be about USD 350 million. The underwriters have a 30-day option to buy up to 750,000 addition
03-25 09:55